DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Schmitz K, Hitzer S, Behrens-Baumann W.
Immune suppression by combination therapy with basiliximab and cyclosporin in high risk keratoplasty. A pilot study.
Ophthalmologe 2002; 99: 38-45
We do not assume any responsibility for the contents of the web pages of other providers.